CELLINK Bioink is the first universal bioink designed to print human tissue models with any commercially available or in-house developed 3D-bioprinting system. The nanosized fibrils make the bioink semi-translucent and is thus compatible with many advanced imaging techniques. Batch-to-batch consistent and temperature-independent shear thinning properties of the bioink ensure the best 3D bioprinting experience, and morphological similarity of cellulose nanofibrils to collagen provides mammalian cells with a milieu that resembles their fibrillar natural matrix. Altogether, this enables you to bioprint complex, cell-laden tissue constructs, such as cartilage, bone grafts, liver cancer models. After bioprinting, CELLINK Bioink crosslinks easily with the included ionic crosslinking agent.
- Bioink comes in 3 mL cartridges.
- Includes crosslinking agent.
- Sterile production and packaging.
- 6 months shelf life.
- For research use only. Not for human use
Specialized Formulations Based off the CELLINK Bioink
|Appearance||White semi-translucent gel|
|Endotoxin level||<5 EU/mL|
|Viscosity||≥7 kPa∙s at 0.01 s-1, ≤3 Pa∙s at 200 s-1, measured at 25°C|
The latest publications using CELLINK Bioink.
Development of 3D-Bioprinted Colitis-Mimicking Model to Assess Epithelial Barrier Function Using Albumin Nano-Encapsulated Anti-Inflammatory Drugs
Almutary, Alnuqaydan, Almatroodi, et al. (2023) Biomimetics 8(1)
A New Solution for In-Situ Monitoring of Extrusion-Based Bioprinting Via Infrared Imaging
Colosimo, Moscatelli, Gugliandolo. (2023)
Additive Manufacturing for Fabrication of Point-of-Care Therapies in Austere Environments
Barnhill, Gaston, Deffenbaugh, et al. (2023) Military Medicine
Non-Invasive Three-Dimensional Cell Analysis in Bioinks by Raman Imaging
Marzi, Fuhrmann, Brauchle, et al. (2022) ACS applied materials & interfaces 14 (27)
In Vitro and In Vivo Models of CLL–T Cell Interactions: Implications for Drug Testing
Hoferkova, Kadakova, Mraz. (2022) Cancers 14 (13)